In the combination with Fluticasone Furoate + Vilanterol (Trial 4 [NCT #01957163] and Trial 5 [NCT #02119286]): Patients were randomly assigned to Incruse Ellipta 62.5 mcg + FF/VI 100 mcg/25 mcg ...

Incruse Ellipta (umeclidinium) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a dry powder that you inhale. It’s typically used ...